Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-41183

Welsbach Technology Metals Acquisition Corp.

(Exact name of registrant as specified in its charter)

Delaware		87-1006702
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

160 S Craig Place
Lombard, Illinois		60148
(Address of principal executive offices)		(Zip Code)

(217) 615-1216
(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class:	Trading Symbol(s)	Name of Each Exchange on Which Registered:
Units, each consisting of one share of common stock, $0.0001 par value, and one right to receive one-tenth of one share of common stock	WTMAU	The Nasdaq Stock Market LLC
Common stock, $0.0001 par value per share	WTMA	The Nasdaq Stock Market LLC
Rights, each exchangeable into one- tenth of one share of common stock	WTMAR	The Nasdaq Stock Market LLC

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐	Large accelerated filer	☐	Accelerated filer
☒	Non-accelerated filer	☒	Smaller reporting company
		☒	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of November 20, 2023, there were 4,456,827 shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding.

WELSBACH TECHNOLOGY METALS ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2023

TABLE OF CONTENTS

		Page
	PART 1 – FINANCIAL INFORMATION
Item 1.	Interim Consolidated Financial Statements (Unaudited)
	Condensed Consolidated Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022	1
	Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 (Unaudited)	2
	Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2023 and 2022 (Unaudited)	3
	Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (Unaudited)	4
	Notes to Condensed Consolidated Financial Statements (Unaudited)	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	26
Item 4.	Control and Procedures	26
	PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	27
Item 1A.	Risk Factors	27
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28
Item 3.	Defaults upon Senior Securities	28
Item 4.	Mine Safety Disclosures	28
Item 5.	Other Information	28
Item 6.	Exhibits	29
	SIGNATURES	30

WELSBACH TECHNOLOGY METALS ACQUISITION CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2023			December 31, 2022
	(Unaudited)
ASSETS
Current assets
Cash	$	94,579		$	309,881
Prepaid expenses and other assets		42,121			25,000
Total current assets		136,700			334,881
Restricted cash		213,182			213,182
Investment held in Trust Account		39,613,658			79,645,156
TOTAL ASSETS	$	39,963,540		$	80,193,219

LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT
Current liabilities
Accounts payable	$	2,791,734		$	1,818,627
Due to affiliates		263,663			205,663
Franchise tax payable		336,155			163,384
Income taxes payable		188,177			180,688
Excise tax payable		583,520			—
Due to shareholders for redemption of Common Stock		15,715,387			—
Convertible promissory notes and working capital loans – related party		2,780,471			1,545,537
Total current liabilities		22,659,107			3,913,899
Deferred underwriting fee payable		2,704,690			2,704,690
TOTAL LIABILITIES		25,363,797			6,618,589

COMMITMENTS AND CONTINGENCIES (NOTE 6)
REDEEMABLE COMMON STOCK
Common Stock subject to possible redemption, $0.0001 par value, 2,172,851 and 7,727,686 shares at redemption value of $10.86 and $10.29 per share at September 30, 2023 and December 31, 2022, respectively		23,587,121			79,514,266

STOCKHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2023 and December 31, 2022		—			—
Common stock; $0.0001 par value; 100,000,000 shares authorized; 2,283,976 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively		228			228
Accumulated deficit		(8,987,606	)		(5,939,864	)
TOTAL STOCKHOLDERS’ DEFICIT		(8,987,378	)		(5,939,636	)
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT	$	39,963,540		$	80,193,219

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

WELSBACH TECHNOLOGY METALS ACQUISITION CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2023			2022			2023			2022
OPERATING EXPENSES
General and administrative	$	555,524		$	1,062,557		$	1,744,482		$	1,852,616
Franchise tax		50,000			50,000			150,000			150,000
Loss from operations		605,524			1,112,557			1,894,482			2,002,616

Other income:
Interest income from investments held in Trust Account		507,906			349,006			1,855,102			461,130
Other income		507,906			349,006			1,855,102			461,130

Loss before provision for income taxes		(97,618	)		(763,551	)		(39,380	)		(1,541,486	)
(Benefit from) provision for income taxes		261,911			(52,582	)		—			(52,582	)
Net income (loss)	$	164,293		$	(816,133	)	$	(39,380	)	$	(1,594,068	)

Weighted average shares outstanding of common stock - redemption feature		3,598,051			7,727,686			4,849,939			7,716,804
Basic and diluted net income (loss) per share of common stock - redemption feature	$	0.03		$	(0.08	)	$	(0.01	)	$	(0.16	)

Weighted average shares outstanding of common stock - no redemption feature		2,283,976			2,227,054			2,283,976			2,013,230
Basic and diluted net income (loss) per share of common stock - no redemption feature	$	0.03		$	(0.08	)	$	(0.01	)	$	(0.16	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

WELSBACH TECHNOLOGY METALS ACQUISITION CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023

	Common stock				Additional paid-in		Accumulated			Total Stockholders’
	Shares		Amount		capital		deficit			Deficit
Balance, January 1, 2023		2,283,976	$	228	$	—	$	(5,939,864	)	$	(5,939,636	)
Accretion of redeemable common stock to redemption value		—		—		—		(750,670	)		(750,670	)
Net loss		—		—		—		(230,201	)		(230,201	)
Balance, March 31, 2023		2,283,976		228		—		(6,920,735	)		(6,920,507	)
Accretion of redeemable common stock to redemption value		—		—		—		(722,985	)		(722,985	)
Net income		—		—		—		26,528			26,528
Balance, June 30, 2023		2,283,976		228		—		(7,617,192	)		(7,616,964	)
Accretion of redeemable common stock to redemption value		—		—		—		(951,187	)		(951,187	)
Excise tax on redemption of Class A common stock								(583,520	)		(583,520	)
Net income		—		—		—		164,293			164,293
Balance, September 30, 2023		2,283,976	$	228	$	—	$	(8,987,606	)	$	(8,987,378	)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

	Common stock						Additional paid-in			Accumulated			Total Stockholders’
	Shares			Amount			capital			deficit			Deficit
Balance, January 1, 2022		2,503,750		$	250		$	—		$	(1,232,073	)	$	(1,231,823	)
Sale of private placement units to the sponsor		4,554			—			45,540			—			45,540
Proceeds from the exercise of over-allotment option allocated to public rights (net of offering costs)		—			—			73,142			—			73,142
Forfeiture of shares by Sponsor to the extent the over-allotment option was not exercised in full		(224,328	)		(22	)		22			—			—
Accretion for redeemable common stock to redemption value		—			—			(118,704	)		(79,666	)		(198,370	)
Net loss		—			—			—			(569,282	)		(569,282	)
Balance, March 31, 2022		2,283,976			228			—			(1,881,021	)		(1,880,793	)
Net loss		—			—			—			(208,653	)		(208,653	)
Balance, June 30, 2022		2,283,976			228			—			(2,089,674	)		(2,089,446	)
Accretion of redeemable common stock to redemption value		—			—			—			(983,176	)		(983,176	)
Net loss		—			—			—			(816,133	)		(816,133	)
Balance, September 30, 2022		2,283,976		$	228		$	—		$	(3,888,983	)	$	(3,888,755	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

WELSBACH TECHNOLOGY METALS ACQUISITION CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the Nine Months Ended September 30,
	2023			2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(39,380	)	$	(1,594,068	)
Adjustments to reconcile net loss to net cash used in operating activities:
Income on investments held in Trust Account		(1,855,102	)		(461,133	)
Changes in operating assets and liabilities:
Prepaid expenses and other assets		(17,121	)		320,216
Due to affiliates		58,000			119,490
Accounts payable		973,107			727,668
Franchise tax payable		172,771			70,642
Income taxes payable		7,489			52,582
Net cash used in operating activities		(700,236	)		(764,603	)

CASH FLOWS FROM INVESTING ACTIVITIES
Cash deposited to Trust Account		(750,000	)		(3,049,628	)
Notes receivable - related party		(124,166	)		—
Repayment of notes receivable - related party		124,166			—
Cash withdrawn from Trust Account in connection with redemption		42,636,600			—
Net cash provided by (used in) investing activities		41,886,600			(3,049,628	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of over-allotment option		—			2,276,860
Proceeds from sale of private units to sponsor		—			45,540
Payment of offering costs		—			(45,538	)
Redemption of common stock - due to stockholders		(42,636,600	)		—
Proceeds from convertible promissory notes and working capital loans - related party		1,234,934			772,769
Net cash (used in) provided by financing activities		(41,401,666	)		3,049,631

NET CHANGE IN CASH AND RESTRICTED CASH		(215,302	)		(764,600	)
CASH AND RESTRICTED CASH, BEGINNING OF PERIOD		523,063			1,200,956
CASH AND RESTRICTED CASH, END OF PERIOD	$	307,761		$	436,356

CASH AND RESTRICTED CASH, END OF PERIOD
Cash	$	94,579		$	436,356
Restricted cash		213,182			—
CASH AND RESTRICTED CASH, END OF PERIOD	$	307,761		$	436,356

Supplemental disclosure on noncash activities:
Deferred underwriting commission payable	$	—		$	79,690
Accretion for redeemable common stock to redemption value	$	2,424,842		$	—
Excise tax on redemption of Class A common stock	$	583,520		$	—
Due to shareholders for redemption of Common Stock	$	15,715,387		$	—

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

WELSBACH TECHNOLOGY METALS ACQUISITION CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2023

Note 1 — Description of Organization and Business Operations and Liquidity

Welsbach Technology Metals Acquisition Corp. (the “Company”) was incorporated in Delaware on May 27, 2021. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

The Company has one subsidiary, WTMA Merger Subsidiary Corp., a direct wholly owned subsidiary of the Company incorporated in the state of Delaware on October 19, 2022. As of September 30, 2023 the subsidiary had no activity.

As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023, relates to the Company’s formation and Initial Public Offering (“IPO”), which is described below and, since the offering, the search for a prospective Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income earned on investments from the proceeds derived from the IPO. The registration statement for the Company’s IPO was declared effective on December 27, 2021. On December 30, 2021, the Company consummated the IPO of 7,500,000 units (“Units”), each Unit containing one share of common stock (the “Public Shares”) and one right to receive 1/10 of one share of common stock upon the consummation of the Business Combination (the “Public Rights”), at $10.00 per Unit generating gross proceeds of $75,000,000, which is discussed in Note 3. The Company has selected December 31 as its fiscal year end.

Simultaneously with the closing of the IPO, the Company consummated the sale of 347,500 private placement units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to the Company’s sponsor, Welsbach Acquisition Holdings LLC (the “Sponsor”) generating gross proceeds of $3,475,000, which is described in Note 4.

The Company granted the underwriters a 45-day option to purchase up to 1,125,000 Units to cover Over-allotment, if any. On January 14, 2022, the underwriters partially exercised the option (the “Over-allotment”) and purchased 227,686 additional Units (the “Over-allotment Units”), generating gross proceeds of $2,276,860.

Upon the closing of the over-allotment on January 14, 2022, the Company consummated a private sale of an additional 4,554 Private Placement Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $45,540. As of January 14, 2022, a total of $77,276,860 of the net proceeds from the IPO (including the Over-allotment Units) and the sale of Private Placement Units has been placed in the Trust Account (defined below). As the over-allotment option was only partially exercised, 224,328 shares of common stock purchased by the Initial Stockholders (as defined below) have been forfeited for no consideration.

Offering costs for the IPO and underwriters’ partial exercise of the over-allotment option amounted to $4,788,446, consisting of $1,545,537 of underwriting fees, $2,704,690 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $538,219 of other costs. As described in Note 6, the $2,704,690 of deferred underwriting fee payable is contingent upon the consummation of a Business Combination, subject to the terms of the underwriting agreement entered into in connection with the IPO (the “Underwriting Agreement”).

Following the closing of the IPO, $75,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Units was placed in a trust account (“Trust Account”). The amounts placed in the Trust Account will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below. On November 8, 2023, to mitigate the risk of the Company being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), the Company liquidated the U.S. government treasury obligations held in the Trust Account and placed all funds in the Trust Account in an interest-bearing deposit account (Note 9).

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account excluding the amounts due under the business combination marketing agreement and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect a Business Combination.

The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable).

All of the Public Shares contain a redemption feature, which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) Subtopic 10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., Public Rights as defined in Note 3), the initial carrying value of the Public Shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20 “Debt with Conversion and other Options”. The Public Shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and are classified as such on the condensed consolidated balance sheets until such date that a redemption event takes place.

Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20.0% or more of the Public Shares sold in the IPO, without the prior consent of the Company.

The Company’s Sponsor, officers and directors and other holders of Founders Shares (the “Initial Stockholders”) have agreed not to propose an amendment to the Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their shares of Common Stock in conjunction with any such amendment.

The Company initially had until September 30, 2022 to complete a Business Combination, 9 months following the consummation of the Company’s IPO, and further extended, as described below, to 12 and 15 months following the IPO, as the Sponsor extended the period of time to consummate a Business Combination two times by an additional three months, pursuant to the terms of the Company’s Certificate of Incorporation and the trust agreement. The Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay the Company’s franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The period of time for the Company to complete a business combination under its amended and restated certificate of incorporation has been extended for a period of 3 months from September 30, 2022 to December 30, 2022 upon the deposit of $772,769 into the Trust Account on September 27, 2022 in accordance with the Company’s amended and restated certificate of incorporation. Subsequently, the period of time for the Company to complete a business combination under its amended and restated certificate of incorporation has been extended for a period of 3 months from December 30, 2022 to March 30, 2023 upon the deposit of $772,769 into the Trust Account on December 23, 2022.

On March 24, 2023, the Company held a special meeting of its stockholders. In connection with the votes to approve the March Extensions (defined below), the stockholders approved the proposal to amend the Company’s charter by allowing the Company to extend (the “Extension”) the date by which it has to consummate a business combination (the “Combination Period”) for up to an additional six months, from March 30, 2023 to up to September 30, 2023, by depositing into the trust account (the “trust account”) $125,000 for each additional one month extension (the “Extension Payment”) in exchange for a non-interest bearing, unsecured promissory note, convertible at the option of the holder, in full or in part, into units at a price of $10.00 per unit, which units will be identical to the private placement units issued in connection with the initial public offering of the Company’s units and repayable upon closing of a business combination (the “Extension Note”).

The Company and Continental Stock Transfer & Trust Company entered into an amendment to the Investment Management Trust Agreement, dated March 24, 2023, by and between Continental Stock Transfer & Trust Company and the Company allowing the Company to extend the Combination Period for up to an additional six months, from March 30, 2023 to up to September 30, 2023 (the “March Extensions”), by depositing into the trust account the Extension Payment each additional one month extension in exchange for an Extension Note.

The period of time for the Company to complete a business combination under its amended and restated certificate of incorporation has been further extended for a period of six (6) months from March 30, 2023 to September 30, 2023 upon the deposit of $125,000 into the Trust Account on March 28, 2023, April 27, 2023, May 26, 2023, June 29, 2023, August 1, 2023 and August 29, 2023 (Note 9) in accordance with the Company’s amended and restated certificate of incorporation.

On March 24, 2023, Holders of 4,097,964 shares of common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.40 per share, for an aggregate redemption amount of approximately $42.6 million, leaving approximately $37.8 million in the trust account, based on the approximately $80.4 million held in the trust account. The amount due to the redeeming stockholders was disbursed on April 10, 2023.

On April 10, 2023, $42,636,600 was disbursed to Holders of shares exercising their right to redeem at the special meeting of the Company’s stockholders held on March 24, 2023 in connection with the vote to approve the March Extensions.

On September 11, 2023, the Company issued a press release to announce that it had entered into a non-binding letter of intent with a target in the critical materials space (the “Target”) for a potential business combination. There can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated.

On September 29, 2023, the Company held a special meeting of its stockholders. The stockholders approved the proposal to amend (the “Charter Amendment”) the Company’s charter by allowing the Company to extend the Combination Period with a target for up to an additional nine months, from September 30, 2023, to up to June 30, 2024 and proposal to amend the Trust Agreement, allowing the Company to extend the Combination Period for up to an additional nine months, from September 30, 2023, to up to June 30, 2024 (the “Trust Amendment” and together with the Charter Amendment, the “September Extensions”), for no contribution to the trust account. In connection with the votes to approve the September Extensions, the holders of 1,456,871 shares of common stock of the Company properly exercised and did not reverse, their right to redeem their shares for cash at a redemption price of $10.79 per share, for an aggregate redemption amount of $15.7 million, leaving approximately $23.4 million in the trust account after the withdrawal of interest to be paid for taxes. As of September 30, 2023, the amounts due to Holders exercising their right to redeem is presented as Due to stockholders for redemption of Common Stock in the accompanying condensed consolidated balance sheets. The amount due to the redeeming stockholders was subsequently disbursed on October 12, 2023 (Note 9).

The Initial Stockholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to its deferred underwriting fees (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per shares held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Risks and Uncertainties

Our results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in Ukraine and the Middle East. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial Business Combination.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

On March 24, 2023 and September 29, 2023, the Company’s stockholders redeemed 4,097,964 and 1,456,871 Common shares for a total of $42,636,600 and $15,715,837, respectively. The Company evaluated the classification and accounting of the stock redemption under ASC 450, “Contingencies”. ASC 450 states that when a loss contingency exists the likelihood that the future event(s) will confirm the loss or impairment of an asset or the incurrence of a liability can range from probable to remote. A contingent liability must be reviewed at each reporting period to determine appropriate treatment. The excise tax is determined at year end based on events that occurred during the year. The excise tax is representative of a contingent liability that is probable of occurring due to the extension to June 30, 2024, past the end of the Company’s current year reporting period. The Company would be required to record a liability in the amount of the excise tax liability which would be calculated as 1% of the shares redeemed during the reporting period. This position would be reviewed at the end of each reporting period for any change in fact. If the SPAC were to completely liquidates and dissolves (within the meaning of § 1.331-1(d)(1)(ii)) during a taxable year (that is, has a final distribution in complete liquidation to which § 331 applies during that taxable year), no distribution by that covered corporation or covered surrogate foreign corporation during that taxable year is a repurchase.

As such the Company has recorded a 1% excise tax liability in the amount of $583,520 on the Company’s condensed balance sheets as of September 30, 2023. The liability does not impact the Company’s condensed statements of operations and is offset against additional paid-in capital or accumulated deficit if additional paid-in capital is not available. This excise tax liability can be offset by future share issuances within the same fiscal year which will be evaluated and adjusted in the period in which the issuances occur. Should the Company liquidate prior to December 31, 2023, the excise tax liability will not be due.

Going Concern, Liquidity and Capital Resources

As of September 30, 2023, the Company had operating cash of $94,579, restricted cash of $213,182 (excess permitted withdrawal), and a working capital deficit of $6,807,020. Further, the Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company has no revenue, and its business plan is dependent on the completion of a Business Combination within the Combination Period. If the Company is unable to compete a Business Combination within the Combination Period, it must liquidate. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within a reasonable period of time, which is considered to be one year from the issuance date of the unaudited condensed consolidated financial statements.

Until the consummation of a Business Combination, the Company will be using funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the business combination. If the Company’s estimates of the costs of identifying a target business, undertaking in-depth due diligence, and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to a Business Combination.

The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management determined that the liquidity condition and date for mandatory liquidation and dissolution raise substantial doubt about the Company’s ability to continue as a going concern through August 30, 2023, the scheduled liquidation date of the Company if it does not complete a Business Combination prior to such date. Management may raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties to meet the Company’s working capital needs and to complete a Business Combination before the mandatory liquidation date. The Company may not be able to obtain additional financing. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. The Company intends to complete a Business Combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate any Business Combination by June 30, 2024. These condensed consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from its inability to consummate a Business Combination or its inability to continue as a going concern.

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in unaudited condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, as filed with the SEC on February 21, 2023. The interim results for the three and nine months ended September 30, 2023 presented are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

Emerging Growth Company

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.

Restricted Cash

As of September 30, 2023, the Company had withdrawn $42,636,600 from Trust Account in connection with redemption. As of December 31, 2022, the Company had withdrawn $298,414 from the trust account for the purpose of paying the Company’s franchise and income taxes. In the fourth quarter of 2022, the Company partially used the amount to pay $85,232 of franchise taxes. The balance of $213,182 was recorded by the Company as an excess permitted withdrawal from the Company’s trust account and as restricted cash, to be utilized to pay outstanding franchise and income taxes. In connection with the issuance of the Extension Note on July 30, 2023, the Company’s independent directors were informed that certain amounts of restricted cash had been used to make payments to vendors for services provided to the Company, and were advanced to the Sponsor in order for the Sponsor to have sufficient liquidity to fund the Extension Note previously announced by the Company on the Current Report on Form 8-K filed with the Securities and Exchange Commission on May 30, 2023, resulting in an aggregate restricted cash deficiency of $142,851 as of June 30, 2023. As of August 1, 2023, the proceeds of the Working Capital Note dated July 30, 2023, which have been funded by the Sponsor, were sufficient to replenish the Company’s restricted cash level to $213,182. As of September 30, 2023 and December 31, 2022, there is a restricted cash balance of $213,182, which will be utilized to pay the outstanding franchise and income taxes.

Investments Held in Trust Account

At September 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest income from investments held in Trust Account in the accompanying consolidated statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Offering Costs associated with the IPO and over-allotment

Offering costs consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs of the IPO amounted to $4,663,218, which was charged against additional paid-in capital and common stock subject to redemption upon the completion of the IPO. Subsequently, additional offering cost of $125,228 was incurred with the Over-allotment in January 2022 and was also charged against additional paid-in capital and common stock subject to redemption in January 2022.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit. As of September 30, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed consolidated financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.

The Company’s effective tax rate was (268.30)% and 6.89% for the three months ended September 30, 2023 and 2022, respectively, 0% and 3.41% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2023 and 2022, primarily due to the valuation allowance on the deferred tax assets and merger and acquisition costs treated as permanent differences.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s unaudited condensed consolidated financial statements and prescribes a recognition threshold and measurement process for unaudited condensed consolidated financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Public Shares sold in the IPO feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. On March 24, 2023, in connection with the votes to approve the March Extensions, the holders of 4,097,964 shares of common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.40 per share, for an aggregate redemption amount of approximately $42.6 million, leaving approximately $37.8 million in the trust account, based on the approximately $80.4 million held in the trust account as of March 22, 2023.

On September 29, 2023, in connection with the votes to approve the September Extensions, the holders of 1,456,871 shares of common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.79 per share, for an aggregate redemption amount of $15.7 million, leaving $23.4 million in the trust account, based on the approximately $39.6 million held in the trust account as of September 27, 2023 after the withdrawal of interest to be paid for taxes.

Accordingly, 2,172,851 and 7,727,686 shares of common stock subject to possible redemption on September 30, 2023 and December 31, 2022, respectively, is presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed consolidated balance sheets.

Immediately upon the closing of the IPO, the Company recognized the accretion from the initial book value to redemption amount value. This method would view the end of the reporting period as if it were also the redemption date for the security. The change in the carrying value of redeemable shares of common stock resulted in charges against additional paid-in capital and accumulated deficit.

The shares of common stock reflected on the condensed consolidated balance sheets are reconciled on the following table:

	September 30, 2023			December 31, 2022
Gross proceeds	$	79,514,266		$	77,276,860
Less:
Fair value of Public Rights at issuance		—			(2,627,413	)
Public shares issuance costs		—			(4,626,437	)
Redemptions		(58,351,987	)		—
Plus:
Accretion of carrying value to redemption value		2,424,842			9,491,256
Redeemable ordinary shares subject to possible redemption	$	23,587,121		$	79,514,266

Net Income (Loss) per Common Share

The Company computes loss per share in accordance with ASC 260-10-45 “Earnings per Share”, which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. The Company’s public common shares have a redemption right, which differ from the common shares that the sponsors hold. Accordingly, the Company has effectively two classes of shares, which are referred to as public common shares and Founder Shares. Income and losses are shared pro rata between the two classes of shares. Basic income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of outstanding common shares during the period. Accretion associated with the common stock subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value.

Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive income (loss) per share excludes all potential common shares if their effect is anti-dilutive. The Company has excluded the Rights from the calculation of diluted income (loss) per share because the Rights are contingent upon the occurrence of future events and any impact would be anti-dilutive. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2023 and 2022. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per common share.

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2023				2022						2023						2022
	Redeemable		Non- redeemable		Redeemable			Non- redeemable			Redeemable			Non- redeemable			Redeemable			Non- redeemable
Basic and diluted net income (loss) per common share
Numerator:
Allocation of net income (loss)	$	100,498	$	63,795	$	(633,549	)	$	(182,584	)	$	(26,772	)	$	(12,608	)	$	(1,264,241	)	$	(329,827	)
Denominator:
Basic and diluted weighted average shares outstanding		3,598,051		2,283,976		7,727,686			2,227,054			4,849,939			2,283,976			7,716,804			2,013,230

Basic and diluted net income (loss) per common share	$	0.03	$	0.03	$	(0.08	)	$	(0.08	)	$	(0.01	)	$	(0.01	)	$	(0.16	)	$	(0.16	)

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2023.

Note 3 — Initial Public Offering and Over-Allotment

Pursuant to the IPO, the Company sold 7,500,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of common stock and one right to receive one-tenth (1/10) of a share of common stock upon consummation of a Business Combination (each, a “Public Right”).

The Company granted the underwriters a 45-day option to purchase up to 1,125,000 Units to cover Over-allotment, if any. On January 14, 2022, the underwriters partially exercised the option and purchased 227,686 additional Units (the “Over-allotment Units”).

On March 24, 2023, in connection with the votes to approve the March Extensions, the holders of 4,097,964 shares of common stock of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.40 per share, for an aggregate redemption amount of approximately $42.6 million, leaving approximately $37.8 million in the trust account, based on the approximately $80.4 million held in the trust account, as of March 22, 2023.

Note 4 — Private Placement

On December 27, 2021, simultaneously with the consummation of the IPO, the Company consummated the issuance and sale (“Private Placement”) of 347,500 Private Placement Units in a private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $3,475,000. Each Private Placement Unit consists of one share of common stock and one right to receive one-tenth (1/10) of a share of common stock upon consummation of a Business Combination.

On January 14, 2022, the Company consummated the sale of an additional 4,554 Private Placement Units, at $10.00 per Private Placement Unit for an aggregate purchase price of $45,540.

A portion of the proceeds from the Private Placement Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units will be worthless.

Note 5 — Related Party Transactions

Founder Shares

On June 25, 2021, the Sponsor purchased 1,437,500 shares (the “Founder Shares”) of the Company’s Class B common stock, par value $0.0001 for an aggregate price of $25,000. On October 13, 2021, the Company effected an exchange of each such Class B shares for 1.5 shares of the Company’s common stock, resulting in the Sponsor holding an aggregate of 2,156,250 Founder Shares. The Company no longer has Class B common stock authorized. The Initial Stockholders had agreed to forfeit up to 281,250 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. On January 14, 2022, the Sponsor forfeited 224,328 Founder Shares for no consideration, due to the underwriters exercise of the over-allotment option in part.

The Founder Shares were placed into an escrow account maintained in New York, New York by Continental Stock Transfer & Trust Company, acting as escrow agent. Subject to certain limited exceptions, 50% of these shares will not be transferred, assigned, sold or released from escrow until the earlier of (i) six months after the date of the consummation of a Business Combination and (ii) the date on which the closing price of our common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after our Business Combination and the remaining 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, we complete a liquidation, merger, stock exchange or other similar transaction, which results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Promissory Note – Related Party

On June 25, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This loan was non-interest bearing and was payable at the consummation of the IPO. As of September 30, 2023 and December 31, 2022, the outstanding balance on the Note had been repaid in full, and borrowings under the promissory note are no longer available.

Due to Affiliates

On December 31, 2021, the Sponsor funded $79,673 in excess of $3,475,000 aggregate purchase price of the Private Placement Units. On January 14, 2022, the Sponsor funded $179,463 in excess of the $45,540 aggregate purchase price of the Private Placement Units sold in conjunction with the exercise of the over-allotment option (for an aggregate of $259,136 in excess purchase price). As of September 30, 2023 and December 31, 2022, there were outstanding of $263,663 and $205,663, which will be repaid from Company’s operating account as soon as practicable, respectively.

Related Party Loans

In addition, in order to finance transaction costs in connection with a Business Combination, certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. These units would be identical to the Private Placement Units.

On July 30, 2023, the Company issued a promissory note (the “Working Capital Note 1”) in the principal amount of $84,000 to the Sponsor in exchange for cash.

On August 30, 2023, the Company issued a promissory note (the “Working Capital Note 2”) in the principal amount of $378,000 to the Sponsor in exchange for cash.

On September 28, 2023, the Company issued a promissory note (the “Working Capital Note 3” and together with Working Capital Note 1 and Working Capital Note 2, the “Working Capital Notes”) in the principal amount of $22,000 to the Sponsor in exchange for cash.

The Working Capital Notes are a non-interest bearing, unsecured promissory notes that will not be repaid in the event that the Company is unable to close an initial business combination unless there are funds available outside the trust account to do so. Such Working Capital Notes would either be paid upon consummation of the Initial Business Combination out of the proceeds of the Trust Account released to the Company or, at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Initial Business Combination into additional private units at a price of $10.00 per unit. Additional Working Capital Notes may be funded at the discretion of the Sponsor, in total amounts for the Working Capital Notes series not to exceed $1.5 million.

The conversion feature was analyzed under ASC 470-20, “Debt with Conversion or Other Options”, the Promissory Notes did not include any premium or discounts. The conversion option did not include elements that would require bifurcation under ASC 815-40, “Derivatives and Hedging.” The convertible note payable and conversion feature does not meet the requirements for classification under ASC 480 and as a result is not required to be accounted for as a liability under ASC 480. In this case, the conversion feature embedded within the convertible promissory note does not require bifurcation and as a result remains embedded within the debt instrument because the convertible promissory note conversion feature does not meet the definition of a derivative as it fails the net settlement requirement. The embedded conversion feature does qualify as equity under ASC 815-40 as the exercise contingency is not based on an observable market or index unrelated to the issuer, the instrument meets the fixed-for-fixed criteria under ASC 815-40-15, meets the requirements for equity classification pursuant to ASC 815-40-25-1 and 25-2 and does not meet the definition of a derivative as it fails the net settlement requirement. Based on this analysis, the scope exception would apply, and the embedded conversion feature would fail to satisfy the third bifurcation condition within ASC 815-15-25-1.

As of September 30, 2023 and December 31, 2022, there were $484,100 and $0, respectively, outstanding under the Working Capital Notes.

Convertible Promissory Note – Related Party

On September 30, 2022, the Company issued a promissory note in the principal amount of $772,769 to the Sponsor in connection with the Extension (Note 1) (“Promissory Note”). The Promissory Note bears no interest and shall be payable upon the earlier to occur of (i) upon consummation of the Company’s initial business combination out of the proceeds of the Trust Account released to the Company’s or (ii) at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit (the “Conversion”).

On December 30, 2022, the Company issued a promissory note in the principal amount of $772,769 to the Sponsor in connection with the Extension (Note 1). The Promissory Note bears no interest and shall be payable upon the earlier to occur of (i) upon consummation of the Company’s initial business combination out of the proceeds of the Trust Account released to the Company’s or (ii) at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit (the “Conversion”).

On March 30, 2023, April 30, 2023, May 30, 2023, June 30, 2023, July 30, 2023 and August 30, 2023, the Company issued six promissory notes to the Sponsor in connection with the Extension (Note 1) in the principal amount of $125,000 for each note. The Promissory Notes bear no interest and shall be payable upon the earlier to occur of (i) upon consummation of the Company’s initial business combination out of the proceeds of the Trust Account released to the Company’s or (ii) at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit (the “Conversion”).

The Promissory Notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, convertible into private units of the post-Business Combination entity at a price of $10.00 per unit. The conversion feature was analyzed under ASC 470-20, “Debt with Conversion or Other Options”, the Promissory Notes did not include any premium or discounts. The conversion option did not include elements that would require bifurcation under ASC 815-40, “Derivatives and Hedging.” The convertible note payable and conversion feature does not meet the requirements for classification under ASC 480 and as a result is not required to be accounted for as a liability under ASC 480. In this case, the conversion feature embedded within the convertible promissory note does not require bifurcation and as a result remains embedded within the debt instrument because the convertible promissory note conversion feature does not meet the definition of a derivative as it fails the net settlement requirement. The embedded conversion feature does qualify as equity under ASC 815-40 as the exercise contingency is not based on an observable market or index unrelated to the issuer, the instrument meets the fixed-for-fixed criteria under ASC 815-40-15, meets the requirements for equity classification pursuant to ASC 815-40-25-1 and 25-2 and does not meet the definition of a derivative as it fails the net settlement requirement. Based on this analysis, the scope exception would apply, and the embedded conversion feature would fail to satisfy the third bifurcation condition within ASC 815-15-25-1.

As of September 30, 2023 and December 31, 2022, there were $2,296,371 and $1,545,537, respectively, outstanding under the Promissory Notes.

Notes Receivable – Related Party

On May 25, 2023, the Sponsor issued a promissory note in the principal amount of $125,000 to the Company. The Promissory Note bears no interest, non-convertible and shall be payable on August 25, 2023 (or within 3 months since date of Date of Note) or earlier at the Company’s discretion. The Sponsor has drawn amount of $124,166 on May 26, 2023 and repaid a $25,000 on June 27, 2023 and $99,166 on July 3, 2023.

As of September 30, 2023 there was no outstanding under the Promissory Note. The foregoing summary of the promissory note is qualified in its entirety by the text of the promissory note, a copy of which is attached as Exhibit 10.2 to the Current Report on Form 8-K filed by the Company on August 1, 2023 and incorporated by reference herein.

Support Services

Commencing on December 27, 2021, the Company entered into an agreement to pay the Sponsor $10,000 per month for the use of office space and administrative support services. For the three and nine months ended September 30, 2023, $30,000 and $90,000 has been expensed related to the agreement, respectively. For the three and nine months ended September 30, 2022, $30,000 and $90,000 has been expensed related to the agreement, respectively.

Note 6 — Commitments and Contingencies

Registration Rights

The holders of Founder Shares, Private Placement Units and units that may be issued upon conversion of Working Capital Loans, will be entitled to registration rights pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option to purchase up to 1,125,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On January 14, 2022, the underwriters purchased an additional 227,686 Units at an offering price of $10.00 per Unit, generating additional gross proceeds of $2,276,860 to the Company. In February 2022, the remaining portion of the underwriters’ over-allotment option expired.

The underwriters were paid a cash underwriting fee of $0.20 per Unit, or $1,545,537 in the aggregate. In addition, $0.35 per Unit, or $2,704,690 in the aggregate will be payable to the underwriters for deferred underwriting commissions, which will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the Underwriting Agreement.

Service Provider Agreements

From time to time the Company has entered into and may enter into agreements with various services providers and advisors, including investment banks, to help us identify targets, negotiate terms of potential Business Combinations, consummate a Business Combination and/or provide other services. In connection with these agreements, the Company may be required to pay such service providers and advisors fees in connection with their services to the extent that certain conditions, including the closing of a potential Business Combination, are met. If a Business Combination does not occur, the Company would not expect to be required to pay these contingent fees. There can be no assurance that the Company will complete a Business Combination.

Backstop Agreement

The Company’s independent directors were informed that on May 3, 2023, the Company and Welsbach Holdings Pte Ltd (the “Backstopper”), an affiliate of the Sponsor, entered into a backstop agreement (the “Backstop Agreement”) pursuant to which the Backstopper guarantees any deficiency of restricted cash which may exist as of September 30, 2023, and agrees to advance funds as needed to remedy any such deficiency. The foregoing summary of the Backstop Agreement is qualified in its entirety by the text of the Backstop Agreement, a copy of which is attached as Exhibit 10.3 to the Current Report on Form 8-K filed by the Company on August 1, 2023 and incorporated by reference herein.

Non-redemption Agreement

On September 27, 2023 and September 29, 2023, the Sponsor entered into Non-Redemption Agreements with various stockholders of the Company pursuant to which these stockholders committed not to redeem their redeemable shares in connection with the special meeting held on September 29, 2023, but still retained their right to redeem in connection with the closing of the Business Combination. The commitment to not redeem was accepted by holders of 2,432,185 shares of redeemable common stock. In consideration of this agreement, the Sponsor agreed to cause the surviving entity (“MergeCo”) of any future WTMA initial business combination to issue to such shareholders a certain number of additional ordinary or common shares of MergeCo immediately following the consummation of an initial business combination, if they continue to hold such Non-Redeemed Shares through the special stockholder meeting.

Advisory Agreement

On September 8, 2023 the Company engaged J.V.B. Financial Group, LLC, acting through its Cohen & Company Capital Markets division (“CCM”) to provide various advisory services related to extension and closing a transaction. The Company shall make a payment to CCM if the following conditions are met (i) the Extension is approved, (ii) the Extension is for at least six months, (iii) a minimum of $25,000,000 remains in the Trust Account immediately following the Extension and (iv) no more than 500,000 shares of the Company were transferred to non-affiliate holders of the Company’s founder shares or Target’s equity in connection with the Extension. CCM shall receive 100,000 common shares or equivalent equity of the publicly listed post-business combination company (the “Post-Closing Company”) (the “Fee Shares”), which Fee Shares shall be issued at the closing of the Business Combination in book entry form in the name of and delivered to CCM (or its designee). The Fee Shares, if issued, shall be duly authorized, validly issued, fully paid and non-assessable and shall be registered for resale under the Act, or otherwise freely tradeable, as of the delivery of the fee shares.

Note 7 — Stockholders’ Deficit

Recapitalization — On June 25, 2021, the Sponsor purchased 1,437,500 shares of Class B common stock for an aggregate purchase price of $25,000. On October 13, 2021, the Company effected an exchange of each such share of Class B common stock for 1.5 shares of our common stock, resulting in the Sponsor holding an aggregate of 2,156,250 founder shares. The Company no longer has Class B common stock authorized.

Common stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were 2,283,976 shares of common stock outstanding excluding 2,172,851 and 7,727,686 shares of common stock subject to possible redemption, respectively.

Note 8 — Fair Value Measurements

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:

Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:

Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

At September 30, 2023 and December 31, 2022, the assets held in the Trust Account were held in treasury funds. All of the Company’s investments held in the Trust Account are classified as trading securities. Through September 30, 2023, the Company withdrew $42,636,600 in connection with redemption of common stock, which includes $837,367 of the interest earned on the Trust Account distributed to the stockholders, and $298,414 of the interest earned on the Trust Account to pay franchise and income taxes of which $213,182 is reported as restricted cash on the accompanying condensed consolidated balance sheets.

On October 12, 2023, $15,715,387 in connection with redemption of common stock, which includes $554,273 of the interest earned on the Trust Account distributed to the stockholders (Note 9).

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 (unaudited) and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

September 30, 2023

Quoted
Prices in
Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

(Level 1)

(Level 2)

(Level 3)

Assets:

Cash and U.S. Treasury Securities

39,613,658

—

December 31, 2022

Quoted
Prices in
Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

(Level 1)

(Level 2)

(Level 3)

Assets:

Cash and U.S. Treasury Securities

79,645,156

—

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed consolidated financial statements were issued. Based upon this review, other than as described below, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.

On October 9, 2023, the Company received a letter (the “Notice”) from the Nasdaq Listing Qualifications department of Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with the requirements of Nasdaq Listing Rule 5450(a)(2) (the “Rule”) for continued listing on Nasdaq. Under the Rule, the Company is required to maintain at least 400 total holders (the “Total Holder Requirement”). The Notice indicates that the Company has 45 calendar days (the “Deadline”) to submit a plan (the “Compliance Plan”) to regain compliance with the Rule. If Nasdaq accepts the Compliance Plan, Nasdaq can grant the Company an extension of up to 180 calendar days from the date of the Notice to evidence compliance. On November 12, 2023 the Company received an extension to regain compliance with the Rule on or before April 8, 2024. The Company intends to regain compliance with the Total Holder Requirement prior to April 8, 2024.

On October 12, 2023, $15,715,387 was disbursed to Holders of shares exercising their right to redeem at the special meeting of the Company’s stockholders held on September 29, 2023 in connection with the vote to approve the September Extensions.

On October 16, 2023, the board of directors (the “Board”) of the Company appointed Mr. Andrew Switaj and Mr. Dominik Michael Oggenfuss (each, a “New Director”) as directors of the Company (the “Appointment”), effective immediately.

In connection with the Appointment, the Board authorized the Company to enter into indemnity agreements with each New Director (the “Indemnity Agreements”). The Company and each New Director consented to and executed the Indemnity Agreements on October 16, 2023.

On November 8, 2023, to mitigate the risk of the Company being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), the Company liquidated the U.S. government treasury obligations held in the Trust Account and placed all funds in the Trust Account in an interest-bearing deposit account.

On November 10, 2023, the Company issued a promissory note (the “Working Capital Note 4”) in the principal amount of $50,000 to the Sponsor in exchange for cash for an aggregate total Working Capital Loan of $534,000 as of the date hereof.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

References in this report to the “Company,” “Welsbach,” “our,” “us” or “we” refer to Welsbach Technology Metals Acquisition Corporation. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Welsbach Acquisition Holdings LLC. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the notes related thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

All statements other than statements of historical fact included in this Quarterly Report including, without limitation, statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. When used in this Quarterly Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or the Company’s management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of many factors, including those set forth under “Cautionary Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Quarterly Report.

Overview

We are a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more target businesses. We intend to effectuate our business combination using cash from the proceeds of our initial public offering and the sale of the placement units that occurred simultaneously with the completion of our IPO, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.

Recent Developments

The Company and Continental Stock Transfer & Trust Company entered into an amendment to the Investment Management Trust Agreement, dated March 24, 2023, by and between Continental Stock Transfer & Trust Company and the Company allowing the Company to extend the Combination Period for up to an additional six months, from March 30, 2023 to up to September 30, 2023, by depositing into the trust account the Extension Payment each additional one month extension in exchange for an Extension Note.

The period of time for the Company to complete a business combination under its amended and restated certificate of incorporation has been further extended for a period of six (6) months from March 30, 2023 to August 30, 2023 upon the deposit of $125,000 into the Trust Account on March 28, 2023, April 27, 2023, May 26, 2023, June 29, 2023, August 1, 2023 and August 29, 2023 in accordance with the Company’s amended and restated certificate of incorporation.

The Company and Continental Stock Transfer & Trust Company entered into an amendment to the Investment Management Trust Agreement, dated September 29, 2023, by and between Continental Stock Transfer & Trust Company and the Company (the “Trust Agreement”) allowing the Company to extend the Combination Period for up to an additional nine months, from September 30, 2023 to up to June 30, 2024 (the “Trust Amendment”), for no contribution to the trust account.

The period of time for the Company to complete a business combination under its amended and restated certificate of incorporation has been further extended for a period of nine (9) months from September 30, 2023 to June 30, 2024.

On November 10, 2023, the Company issued a promissory note (the “Working Capital Note 4” and together with Working Capital Note 1, Working Capital Note 2 and Working Capital Note 3 (each as defined below), the “Working Capital Notes”) in the principal amount of $50,000 to the Sponsor in exchange for cash for an aggregate total Working Capital Loan of $534,000 as of the date hereof.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities for the three and nine months ended September 30, 2023 were in connection with the search for a prospective initial Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination, at the earliest. We expect to generate non-operating income in the form of interest income from the proceeds of the IPO placed in the Trust Account. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

For the three months ended September 30, 2023, we had a net income of $164,293, which primarily consists of interest and dividend earned on marketable securities held in the Trust Account in total of $507,906 and a benefit from income taxes of $261,911, offset by operating expenses of $555,524 and accrual of Delaware franchise taxes of $50,000.

For the nine months ended September 30, 2023, we had a net loss of $39,380, which primarily consists of operating expenses of $1,744,482 and accrual of Delaware franchise taxes of $150,000, offset by interest and dividend earned on marketable securities held in the Trust Account in total of $ $1,855,102.

For the three months ended September 30, 2022, we had a net loss of $816,133, which primarily consists of operating expenses of $1,062,557, accrual of Delaware franchise taxes of $50,000, and provision for income taxes of $52,582, offset by interest and dividend earned on marketable securities held in the Trust Account in total of $349,006.

For the nine months ended September 30, 2022, we had a net loss of $1,594,068, respectively, which primarily consists of operating expenses of $1,852,616, accrual of Delaware franchise taxes of $150,000, and provision for income taxes of $52,582, offset by interest and dividend earned on marketable securities held in the Trust Account in total of $461,130.

Liquidity, Capital Resources and Going Concern

On December 30, 2021, the Company consummated the IPO of 7,500,000 units, each Unit containing one share of common stock and one right to receive 1/10 of one share of common stock upon the consummation of the Business Combination, generating gross proceeds of $75,000,000, which is discussed in Note 3 to the unaudited condensed consolidated financial statements.

The Company granted the underwriters a 45-day option to purchase up to 1,125,000 Units to cover Over-allotment, if any. On January 14, 2022, the underwriters partially exercised the option and purchased 227,686 additional Units (the “Over-allotment Units”), generating gross proceeds of $2,276,860.

Upon the closing of the Over-allotment on January 14, 2022, the Company consummated a private sale of an additional 4,554 Private Placement Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $45,540. As of January 14, 2022, a total of $77,276,860 of the net proceeds from the IPO (including the Over-allotment Units) and the sale of Private Placement Units has been placed in the Trust Account. As the over-allotment option was only partially exercised, 224,328 shares of Common stock purchased by the Initial Stockholders have been forfeited for no consideration.

Offering costs for the IPO amounted to $4,663,218, consisting of $1,500,000 of underwriting fees, $2,625,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $538,218 of other costs. The deferred underwriting fee payable of $2,704,690 is contingent upon the consummation of a Business Combination by March 31, 2023, subject to the terms of the underwriting agreement.

For the three months ended September 30, 2023, cash used in operating activities was $700,236. Net cash provided by investing activities was $41,886,600 and net cash used in financing activities was $41,401,666 mainly reflecting the redemptions of common stock – due to stockholders exercising their redemption rights in connection with the Extension and proceeds from convertible promissory notes entered into with the Sponsor.

For the nine months ended September 30, 2022, cash used in operating activities was $764,603. Net cash used in investing activities was $3,049,628 and net cash provided by financing activities was $3,049,631 mainly reflecting the proceeds of our IPO and subsequent deposit into the trust account.

At September 30, 2023, we had cash and marketable securities held in the trust account of $39,613,658. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less income taxes payable), to complete our business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. The Company had withdrawn $298,414 from the trust account to pay franchise and income taxes and $42,636,600 to disburse to Holders of shares exercising their right to redeem at the special meeting of the Company’s stockholders held on March 24, 2023 in connection with the vote to approve the March Extensions.

At September 30, 2023, we had operating cash of $94,579 and restricted cash of $213,182 (excess permitted withdrawal) outside of the trust account. We have used and intend to continue to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination. In connection with the issuance of the Extension Note on July 30, 2023, the Company’s independent directors were informed that certain amounts of restricted cash had been used to make payments to vendors for services provided to the Company, and were advanced to the Sponsor in order for the Sponsor to have sufficient liquidity to fund the Extension Note previously announced by the Company on the Current Report on Form 8-K filed with the Securities and Exchange Commission on May 30, 2023, resulting in an aggregate restricted cash deficiency of $142,851 as of June 30, 2023. As of August 1, 2023, the proceeds of the Working Capital Note dated July 30, 2023, which have been funded by the Sponsor, were sufficient to replenish the Company’s restricted cash level to $213,182. As of September 30, 2023 and December 31, 2022, there is outstanding balance of $213,182 which will be utilized to pay the outstanding franchise and income taxes.

We monitor the adequacy of our working capital in order to meet the expenditures required for operating our business prior to our initial business combination. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our business combination, in which case we may issue additional securities or incur debt in connection with such business combination. If we are unable to complete our initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account.

Related Party Transactions

Promissory Note – Related Party

On June 25, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This loan was non-interest bearing and was payable at the consummation of the IPO. As of September 30, 2023, and December 31, 2022, the outstanding balance on the Note has been repaid in full, and borrowings under the promissory note are no longer available.

Related Party Loans

On September 30, 2022, the Company issued a first promissory note in the principal amount of $772,769 to the Sponsor in connection with the Extension. The First Promissory Note bears no interest and shall be payable upon the earlier to occur of (i) upon consummation of the Company’s initial business combination out of the proceeds of the Trust Account released to the Company’s or (ii) at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit.

On December 30, 2022, the Company issued a second promissory note in the principal amount of $772,769 to the Sponsor in connection with the Extension. The Second Promissory Note bears no interest and shall be payable upon the earlier to occur of (i) upon consummation of the Company’s initial business combination out of the proceeds of the Trust Account released to the Company’s or (ii) at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit.

On July 30, 2023, the Company issued a promissory note (the “Working Capital Note 1”) in the principal amount of $84,000 to the Sponsor in exchange for cash.

On August 30, 2023, the Company issued a promissory note (the “Working Capital Note 2”) in the principal amount of $378,000 to the Sponsor in exchange for cash.

On September 28, 2023, the Company issued a promissory note (the “Working Capital Note 3”) in the principal amount of $22,000 to the Sponsor in exchange for cash.

The promissory notes and Working Capital Notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, convertible into private units of the post-Business Combination entity at a price of $10.00 per unit. The conversion feature was analyzed under ASC 470-20, “Debt with Conversion or Other Options”, the note did not include any premium or discounts. The conversion option did not include elements that would require bifurcation under ASC 815-40, “Derivatives and Hedging.” The convertible note payable and conversion feature does not meet the requirements for classification under ASC 480 and as a result is not required to be accounted for as a liability under ASC 480. In this case, the conversion feature embedded within the convertible promissory note does not require bifurcation and as a result remains embedded within the debt instrument because the convertible promissory note conversion feature does not meet the definition of a derivative as it fails the net settlement requirement. The embedded conversion feature does qualify as equity under ASC 815-40 as the exercise contingency is not based on an observable market or index unrelated to the issuer, the instrument meets the fixed-for-fixed criteria under ASC 815-40-15, meets the requirements for equity classification pursuant to ASC 815-40-25-1 and 25-2 and does not meet the definition of a derivative as it fails the net settlement requirement. Based on this analysis, the scope exception would apply, and the embedded conversion feature would fail to satisfy the third bifurcation condition within ASC 815-15-25-1.

As of September 30, 2023 and December 31, 2022, there were $2,296,371 and $1,545,537, respectively, outstanding under the Promissory Notes.

As of September 30, 2023 and December 31, 2022, there were $484,100 and $0, respectively, outstanding under the Working Capital Notes.

In addition, on May 25, 2023, the Sponsor issued a promissory note in the principal amount of $125,000 to the Company which the Company accounted for as a receivable due from a related party. The Promissory Note bears no interest, non-convertible and shall be payable on August 25, 2023 or earlier at the Company’s discretion. The Sponsor had drawn $124,166 under this note on May 26, 2023 and repaid a $25,000 on June 27, 2023 and $99,166 on July 3, 2023. As of September 30, 2023 there was no outstanding under the Promissory Note, which has subsequently been repaid by the Sponsor.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2023. We do not participate in transactions that create relationships with entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual obligations

We do not have any long-term debt, capital lease obligations or operating lease obligations.

The underwriters were paid a cash underwriting discount of $0.20 per Unit on the offering, or $1,545,537 in the aggregate at the closing of the IPO and the over-allotment option. In addition, the underwriters are entitled to a deferred underwriting commissions of $0.35 per unit, or $2,704,690 from the closing of the IPO.

The Company issued a first promissory note in the principal amount of $772,769 to the Sponsor. The First Promissory Note bears no interest and shall be payable upon the earlier to occur of (i) upon consummation of the Company’s initial business combination out of the proceeds of the Trust Account released to the Company’s or (ii) at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit.

The Company issued a second promissory note in the principal amount of $772,769 to the Sponsor. The Second Promissory Note bears no interest and shall be payable upon the earlier to occur of (i) upon consummation of the Company’s initial business combination out of the proceeds of the Trust Account released to the Company’s or (ii) at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit.

The Company issued six promissory notes in the principal amount of $125,000 to the Sponsor. The Promissory Notes bears no interest and shall be payable upon the earlier to occur of (i) upon consummation of the Company’s initial business combination out of the proceeds of the Trust Account released to the Company’s or (ii) at the Sponsor’s discretion, converted, in full or in part, upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit.

On July 30, 2023, the Company issued Working Capital Note 1 in the principal amount of $84,000 to the Sponsor in exchange for cash.

On August 30, 2023, the Company issued Working Capital Note 2 in the principal amount of $378,000 to the Sponsor in exchange for cash.

On September 28, 2023, the Company issued Working Capital Note 3 in the principal amount of $22,000 to the Sponsor in exchange for cash.

As of September 30, 2023 and December 31, 2022, there were $2,296,371 and $1,545,537, respectively, outstanding under the Promissory Notes.

As of September 30, 2023 and December 31, 2022, there were $484,100 and $0, respectively, outstanding under the Working Capital Notes.

Common Stock Subject to Possible Redemption

We account for our common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our condensed consolidated balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

Net Income (Loss) per Share of Common Stock

The Company computes income (loss) per share in accordance with ASC 260-10-45 “Earnings per Share”, which requires presentation of both basic and diluted income (loss) per share on the face of the statement of operations. The Company’s public common shares have a redemption right, which differ from the common shares that the sponsors hold. Accordingly, the Company has effectively two classes of shares, which are referred to as public common shares and Founder Shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture by the Sponsor. At September 30, 2023, the Company did not have any dilutive securities and/or other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

Recent Accounting Pronouncements

Factors That May Adversely Affect Our Results of Operations

Our results of operations and our ability to complete an initial business combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.

JOBS Act

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our unaudited condensed consolidated financial statements may not be comparable to companies that comply with public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the unaudited condensed consolidated financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of executive compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.

Critical Accounting Policies

The preparation of unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer (together, the “Certifying Officers”), we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Report.

Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Certifying Officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

Not applicable.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

As a smaller reporting company, we are not required to include risk factors in this Quarterly Report on Form 10-Q. As a smaller reporting company, we are not required to include risk factors in this Report. However, below is a partial list of material risks, uncertainties and other factors that could have a material effect on the Company and its operations:

●

We are a blank check company with no revenue or basis to evaluate our ability to select a suitable business target;

●

We may not be able to select an appropriate target business or businesses and complete our initial business combination in the prescribed time frame;

●

Our expectations around the performance of a prospective target business or businesses may not be realized;

●

We may not be successful in retaining or recruiting required officers, key employees or directors following our initial business combination;

●

Our officers and directors may have difficulties allocating their time between the Company and other businesses and may potentially have conflicts of interest with our business or in approving our initial business combination;

●

We may not be able to obtain additional financing to complete our initial business combination or reduce the number of shareholders requesting redemption;

●

We may issue our shares to investors in connection with our initial business combination at a price that is less than the prevailing market price of our shares at that time;

●

You may not be given the opportunity to choose the initial business target or to vote on the initial business combination;

●

Trust account funds may not be protected against third party claims or bankruptcy;

●

An active market for our public securities’ may not develop and you will have limited liquidity and trading;

●

The availability to us of funds from interest income on the trust account balance may be insufficient to operate our business prior to the business combination;

●

Our financial performance following a business combination with an entity may be negatively affected by their lack an established record of revenue, cash flows and experienced management;

●

There may be more competition to find an attractive target for an initial business combination, which could increase the costs associated with completing our initial business combination and may result in our inability to find a suitable target;

●

Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination;

●

We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and give rise to increased costs and risks that could negatively impact our operations and profitability;

●

We may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us after the initial public offering, which may include acting as a financial advisor in connection with an initial business combination or as placement agent in connection with a related financing transaction. Our underwriters are entitled to receive deferred underwriting commissions that will be released from the trust account only upon a completion of an initial business combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such additional services to us after the initial public offering, including, for example, in connection with the sourcing and consummation of an initial business combination;

●

We may attempt to complete our initial business combination with a private company about which little information is available, which may result in a business combination with a company that is not as profitable as we suspected, if at all;

●

Since our initial stockholders will lose their entire investment in us if our initial business combination is not completed (other than with respect to any public shares they may acquire during or after our initial public offering), and because our sponsor, officers and directors may profit substantially even under circumstances in which our public stockholders would experience losses in connection with their investment, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination;

●

Changes in laws or regulations or how such laws or regulations are interpreted or applied, or a failure to comply with any laws or regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations;

●

If the funds held outside of our trust account are insufficient to allow us to operate until at least June 30, 2024 (or such date as extended by our charter), our ability to fund our search for a target business or businesses or complete an initial business combination may be adversely affected;

●

Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a going concern, since we will cease all operations except for the purpose of liquidating if we are unable to complete an initial business combination by June 30, 2024 (or such date as extended by our charter);

●

The value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our common stock at such time is substantially less than $10.00 per share;

●

Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not completed our initial business combination within the required time period, our public stockholders may receive only approximately $10.00 per share, or less than such amount in certain circumstances, on the liquidation of our trust account and our rights will expire worthless; and

●

Our ability to identify a target and to consummate an initial business combination may be adversely affected by economic uncertainty and volatility in the financial markets, including as a result of the military conflict in Ukraine.

For the complete list of risks relating to our operations, see the section titled “Risk Factors” contained in our Registration Statement on Form S-1/A, filed with the SEC on December 15, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

There are no transactions that have not been previously included in a Current Report on Form 8-K.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

Not Applicable.

ITEM 6. EXHIBITS, CONSOLIDATED FINANCIAL STATEMENT SCHEDULES.

The following documents are filed as exhibits to this Quarterly Report on Form 10-Q.

EXHIBIT INDEX

Exhibit Number		Description of Document
3.1		Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Welsbach Technology Metals Acquisitions Corp., dated September 29, 2023 (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed with the SEC on October 3, 2023).
10.1		Form of Extension Note issued by the Registrant to Welsbach Acquisition Holdings LLC (incorporated by reference to Exhibit 10.12 to the Registrant’s Form 10-K filed with the SEC on February 21, 2023)
10.2		Amendment to the Investment Management Trust Agreement, by and between Welsbach Technology Metals Acquisitions Corp. and Continental Stock Transfer & Trust Company, dated September 29, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K filed with the SEC on October 3, 2023).
10.3		Form of Non-Redemption Agreement (incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K, filed with the Securities and Exchange Commission on September 26, 2023).
10.4		Form of Working Capital Note issued to Welsbach Acquisition Holdings LLC, (incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K filed with the SEC on August 1, 2023).
10.5		Sponsor / Company Promissory Note dated as of May 25, 2023 (incorporated by reference to Exhibit 10.2 to the Registrant’s Form 8-K filed with the SEC on August 1, 2023).
10.6		Backstop Agreement dated as of May 3, 2023 (incorporated by reference to Exhibit 10.3 to the Registrant’s Form 8-K filed with the SEC on August 1, 2023).
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document.
101.SCH*		Inline XBRL Taxonomy Extension Schema Document.
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Furnished herewith.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WELSBACH TECHNOLOGY METALS ACQUISITION CORP.

Date: November 20, 2023	By:	/s/ Daniel Mamadou
	Name:	Daniel Mamadou
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Date: November 20, 2023	By:	/s/ John Stanfield
	Name:	John Stanfield
	Title:	Chief Financial Officer
		(Principal Accounting and Financial Officer)

0.01 0.03 0.08 0.16 0.01 0.03 0.08 0.16 2013230 2227054 2283976 2283976 3598051 4849939 7716804 7727686 0.01 0.01 0.03 0.03 0.08 0.08 0.16 0.16 false --12-31 Q3 0001866226 0001866226 2023-01-01 2023-09-30 0001866226 wtma:UnitsEachConsistingOfOneShareOfCommonStock00001ParValueAndOneRightToReceiveOnetenthOfOneShareOfCommonStockMember 2023-01-01 2023-09-30 0001866226 wtma:CommonStock00001ParValuePerShareMember 2023-01-01 2023-09-30 0001866226 wtma:RightsEachExchangeableIntoOneTenthOfOneShareOfCommonStockMember 2023-01-01 2023-09-30 0001866226 2023-11-20 0001866226 2023-09-30 0001866226 2022-12-31 0001866226 2023-07-01 2023-09-30 0001866226 2022-07-01 2022-09-30 0001866226 2022-01-01 2022-09-30 0001866226 wtma:RedemptionFeatureMember 2023-07-01 2023-09-30 0001866226 wtma:RedemptionFeatureMember 2022-07-01 2022-09-30 0001866226 wtma:RedemptionFeatureMember 2023-01-01 2023-09-30 0001866226 wtma:RedemptionFeatureMember 2022-01-01 2022-09-30 0001866226 wtma:NoRedemptionFeatureMember 2023-07-01 2023-09-30 0001866226 wtma:NoRedemptionFeatureMember 2022-07-01 2022-09-30 0001866226 wtma:NoRedemptionFeatureMember 2023-01-01 2023-09-30 0001866226 wtma:NoRedemptionFeatureMember 2022-01-01 2022-09-30 0001866226 us-gaap:CommonStockMember 2022-12-31 0001866226 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001866226 us-gaap:RetainedEarningsMember 2022-12-31 0001866226 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001866226 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001866226 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001866226 2023-01-01 2023-03-31 0001866226 us-gaap:CommonStockMember 2023-03-31 0001866226 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001866226 us-gaap:RetainedEarningsMember 2023-03-31 0001866226 2023-03-31 0001866226 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001866226 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001866226 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001866226 2023-04-01 2023-06-30 0001866226 us-gaap:CommonStockMember 2023-06-30 0001866226 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001866226 us-gaap:RetainedEarningsMember 2023-06-30 0001866226 2023-06-30 0001866226 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001866226 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001866226 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001866226 us-gaap:CommonStockMember 2023-09-30 0001866226 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001866226 us-gaap:RetainedEarningsMember 2023-09-30 0001866226 us-gaap:CommonStockMember 2021-12-31 0001866226 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001866226 us-gaap:RetainedEarningsMember 2021-12-31 0001866226 2021-12-31 0001866226 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001866226 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001866226 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001866226 2022-01-01 2022-03-31 0001866226 us-gaap:CommonStockMember 2022-03-31 0001866226 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001866226 us-gaap:RetainedEarningsMember 2022-03-31 0001866226 2022-03-31 0001866226 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001866226 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001866226 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001866226 2022-04-01 2022-06-30 0001866226 us-gaap:CommonStockMember 2022-06-30 0001866226 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001866226 us-gaap:RetainedEarningsMember 2022-06-30 0001866226 2022-06-30 0001866226 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001866226 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001866226 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001866226 us-gaap:CommonStockMember 2022-09-30 0001866226 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001866226 us-gaap:RetainedEarningsMember 2022-09-30 0001866226 2022-09-30 0001866226 us-gaap:IPOMember 2021-12-30 0001866226 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:IPOMember 2021-12-30 0001866226 2021-12-30 2021-12-30 0001866226 us-gaap:PrivatePlacementMember 2023-09-30 0001866226 wtma:SponsorMember 2023-01-01 2023-09-30 0001866226 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-01-14 0001866226 us-gaap:PrivatePlacementMember 2022-01-01 2022-01-14 0001866226 us-gaap:PrivatePlacementMember 2022-01-14 0001866226 us-gaap:IPOMember 2022-01-01 2022-01-14 0001866226 us-gaap:CommonStockMember 2022-01-01 2022-01-14 0001866226 us-gaap:IPOMember 2023-09-30 0001866226 us-gaap:IPOMember 2023-01-01 2023-09-30 0001866226 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001866226 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-01-01 2023-09-30 0001866226 2022-09-27 0001866226 2022-12-23 0001866226 2023-03-01 2023-03-24 0001866226 2023-03-24 0001866226 2023-03-28 0001866226 2023-04-27 0001866226 2023-05-26 0001866226 2023-06-29 0001866226 2023-08-01 0001866226 2023-08-29 0001866226 wtma:TrustAccountMember us-gaap:CommonStockMember 2023-03-24 0001866226 wtma:TrustAccountMember 2023-03-24 0001866226 2023-04-10 0001866226 2023-09-01 2023-09-29 0001866226 2023-09-29 0001866226 2022-08-01 2022-08-16 0001866226 us-gaap:RestrictedStockMember 2022-12-31 2022-12-31 0001866226 2022-10-01 2022-12-31 0001866226 wtma:SponsorMember 2023-09-30 0001866226 2022-01-01 2022-12-31 0001866226 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001866226 us-gaap:CommonStockMember 2023-03-24 2023-03-24 0001866226 us-gaap:CommonStockMember 2023-03-24 0001866226 2023-03-22 0001866226 2023-09-29 2023-09-29 0001866226 2023-09-27 0001866226 wtma:RedeemableMember 2023-07-01 2023-09-30 0001866226 wtma:NonRedeemableMember 2023-07-01 2023-09-30 0001866226 wtma:RedeemableMember 2022-07-01 2022-09-30 0001866226 wtma:NonRedeemableMember 2022-07-01 2022-09-30 0001866226 wtma:RedeemableMember 2023-01-01 2023-09-30 0001866226 wtma:NonRedeemableMember 2023-01-01 2023-09-30 0001866226 wtma:RedeemableMember 2022-01-01 2022-09-30 0001866226 wtma:NonRedeemableMember 2022-01-01 2022-09-30 0001866226 us-gaap:OverAllotmentOptionMember 2022-01-14 2022-01-14 0001866226 2023-03-24 2023-03-24 0001866226 us-gaap:PrivatePlacementMember 2021-12-27 2021-12-27 0001866226 us-gaap:PrivatePlacementMember 2021-12-27 0001866226 us-gaap:PrivatePlacementMember 2022-01-14 2022-01-14 0001866226 2022-01-14 2022-01-14 0001866226 wtma:FounderSharesMember us-gaap:CommonClassBMember 2021-06-25 0001866226 wtma:FounderSharesMember 2021-06-01 2021-06-25 0001866226 us-gaap:CommonClassBMember 2021-10-01 2021-10-13 0001866226 wtma:FounderSharesMember 2021-10-13 0001866226 wtma:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-10-01 2021-10-13 0001866226 2022-01-01 2022-01-14 0001866226 wtma:BusinessCombinationMember wtma:FounderSharesMember 2023-09-30 0001866226 us-gaap:IPOMember 2021-06-01 2021-06-25 0001866226 us-gaap:PrivatePlacementMember 2021-12-01 2021-12-31 0001866226 2023-07-01 2023-07-30 0001866226 2023-08-01 2023-08-30 0001866226 2023-09-01 2023-09-28 0001866226 2023-09-28 0001866226 2023-01-01 2023-09-28 0001866226 2022-09-01 2022-09-30 0001866226 2022-12-01 2022-12-30 0001866226 2023-03-01 2023-03-30 0001866226 2023-05-01 2023-05-25 0001866226 2023-05-01 2023-05-26 0001866226 2023-06-01 2023-06-27 0001866226 2023-07-01 2023-07-03 0001866226 2021-12-01 2021-12-27 0001866226 srt:ChiefFinancialOfficerMember 2023-01-01 2023-09-30 0001866226 us-gaap:OverAllotmentOptionMember 2022-01-14 0001866226 2023-09-08 0001866226 us-gaap:CommonClassBMember 2021-06-25 0001866226 us-gaap:CommonClassBMember 2021-10-13 0001866226 2023-10-12 0001866226 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001866226 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001866226 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001866226 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001866226 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001866226 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001866226 us-gaap:SubsequentEventMember 2023-10-01 2023-10-12 0001866226 us-gaap:SubsequentEventMember 2023-11-10 0001866226 us-gaap:SubsequentEventMember 2023-11-01 2023-11-10 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Daniel Mamadou, Chief Executive Officer of Welsbach Technology Metals Acquisition Corp., certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Welsbach Technology Metals Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 20, 2023

By:	/s/ Daniel Mamadou
	Name:	Daniel Mamadou
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, John Stanfield, Chief Financial Officer of Welsbach Technology Metals Acquisition Corp., certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Welsbach Technology Metals Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 20, 2023

By:	/s/ John Stanfield
	Name:	John Stanfield
	Title:	Chief Financial Officer
		(Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. 1350

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report on Form 10-Q of Welsbach Technology Metals Acquisition Corp. (the “Company”) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Daniel Mamadou, the Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Dated: November 20, 2023	By:	/s/ Daniel Mamadou
		Name:	Daniel Mamadou
		Title:	Chief Executive Officer
			(Principal Executive Officer)

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Welsbach Technology Metals Acquisition Corp. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. 1350

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report on Form 10-Q of Welsbach Technology Metals Acquisition Corp. (the “Company”) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, John Stanfield, the Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Dated: November 20, 2023	By:	/s/ John Stanfield
		Name:	John Stanfield
		Title:	Chief Financial Officer
			(Principal Financial Officer)

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2023	Nov. 20, 2023
Document Information Line Items
Entity Registrant Name	Welsbach Technology Metals Acquisition Corp.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		4,456,827
Amendment Flag	false
Entity Central Index Key	0001866226
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-41183
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-1006702
Entity Address, Address Line One	160 S Craig Place
Entity Address, City or Town	Lombard
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60148
City Area Code	(217)
Local Phone Number	615-1216
Entity Interactive Data Current	Yes
Units, each consisting of one share of common stock, $0.0001 par value, and one right to receive one-tenth of one share of common stock
Document Information Line Items
Trading Symbol	WTMAU
Title of 12(b) Security	Units, each consisting of one share of common stock, $0.0001 par value, and one right to receive one-tenth of one share of common stock
Security Exchange Name	NASDAQ
Common stock, $0.0001 par value per share
Document Information Line Items
Trading Symbol	WTMA
Title of 12(b) Security	Common stock, $0.0001 par value per share
Security Exchange Name	NASDAQ
Rights, each exchangeable into one- tenth of one share of common stock
Document Information Line Items
Trading Symbol	WTMAR
Title of 12(b) Security	Rights, each exchangeable into one- tenth of one share of common stock
Security Exchange Name	NASDAQ

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 94,579	$ 309,881
Prepaid expenses and other assets	42,121	25,000
Total current assets	136,700	334,881
Restricted cash	213,182	213,182
Investment held in Trust Account	39,613,658	79,645,156
TOTAL ASSETS	39,963,540	80,193,219
Current liabilities
Accounts payable	2,791,734	1,818,627
Due to affiliates	263,663	205,663
Franchise tax payable	336,155	163,384
Income taxes payable	188,177	180,688
Excise tax payable	583,520
Due to shareholders for redemption of Common Stock	15,715,387
Convertible promissory notes and working capital loans – related party	2,780,471	1,545,537
Total current liabilities	22,659,107	3,913,899
Deferred underwriting fee payable	2,704,690	2,704,690
TOTAL LIABILITIES	25,363,797	6,618,589
COMMITMENTS AND CONTINGENCIES (NOTE 6)
REDEEMABLE COMMON STOCK
Common Stock subject to possible redemption, $0.0001 par value, 2,172,851 and 7,727,686 shares at redemption value of $10.86 and $10.29 per share at September 30, 2023 and December 31, 2022, respectively	23,587,121	79,514,266
STOCKHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2023 and December 31, 2022
Common stock; $0.0001 par value; 100,000,000 shares authorized; 2,283,976 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	228	228
Accumulated deficit	(8,987,606)	(5,939,864)
TOTAL STOCKHOLDERS’ DEFICIT	(8,987,378)	(5,939,636)
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT	$ 39,963,540	$ 80,193,219

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Common stock subject to possible redemption, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock subject to shares at redemption	2,172,851	7,727,686
Common stock subject to possible redemption, per share (in Dollars per share)	$ 10.86	$ 10.29
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	2,283,976	2,283,976
Common stock, shares outstanding	2,283,976	2,283,976

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
OPERATING EXPENSES
General and administrative	$ 555,524	$ 1,062,557	$ 1,744,482	$ 1,852,616
Franchise tax	50,000	50,000	150,000	150,000
Loss from operations	605,524	1,112,557	1,894,482	2,002,616
Other income:
Interest income from investments held in Trust Account	507,906	349,006	1,855,102	461,130
Other income	507,906	349,006	1,855,102	461,130
Loss before provision for income taxes	(97,618)	(763,551)	(39,380)	(1,541,486)
(Benefit from) provision for income taxes	261,911	(52,582)		(52,582)
Net income (loss)	$ 164,293	$ (816,133)	$ (39,380)	$ (1,594,068)
Redemption Feature
Other income:
Weighted average shares outstanding of common stock (in Shares)	3,598,051	7,727,686	4,849,939	7,716,804
Basic and diluted net income (loss) per share of common stock (in Dollars per share)	$ 0.03	$ (0.08)	$ (0.01)	$ (0.16)
No Redemption Feature
Other income:
Weighted average shares outstanding of common stock (in Shares)	2,283,976	2,227,054	2,283,976	2,013,230
Basic and diluted net income (loss) per share of common stock (in Dollars per share)	$ 0.03	$ (0.08)	$ (0.01)	$ (0.16)

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Redemption Feature
Diluted net income (loss) per share of common stock	$ (0.03)	$ (0.08)	$ (0.01)	$ (0.16)
No Redemption Feature
Diluted net income (loss) per share of common stock	$ (0.03)	$ (0.08)	$ (0.01)	$ (0.16)

Condensed Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)	Common stock	Additional paid-in capital	Accumulated deficit	Total
Balance at Dec. 31, 2021	$ 250		$ (1,232,073)	$ (1,231,823)
Balance (in Shares) at Dec. 31, 2021	2,503,750
Sale of private placement units to the sponsor		45,540		45,540
Sale of private placement units to the sponsor (in Shares)	4,554
Proceeds from the exercise of over-allotment option allocated to public rights (net of offering costs)		73,142		73,142
Forfeiture of shares by Sponsor to the extent the over-allotment option was not exercised in full	$ (22)	22
Forfeiture of shares by Sponsor to the extent the over-allotment option was not exercised in full (in Shares)	(224,328)
Accretion of redeemable common stock to redemption value		(118,704)	(79,666)	(198,370)
Net income (loss)			(569,282)	(569,282)
Balance at Mar. 31, 2022	$ 228		(1,881,021)	(1,880,793)
Balance (in Shares) at Mar. 31, 2022	2,283,976
Balance at Dec. 31, 2021	$ 250		(1,232,073)	(1,231,823)
Balance (in Shares) at Dec. 31, 2021	2,503,750
Net income (loss)				(1,594,068)
Balance at Sep. 30, 2022	$ 228		(3,888,983)	(3,888,755)
Balance (in Shares) at Sep. 30, 2022	2,283,976
Balance at Mar. 31, 2022	$ 228		(1,881,021)	(1,880,793)
Balance (in Shares) at Mar. 31, 2022	2,283,976
Net income (loss)			(208,653)	(208,653)
Balance at Jun. 30, 2022	$ 228		(2,089,674)	(2,089,446)
Balance (in Shares) at Jun. 30, 2022	2,283,976
Accretion of redeemable common stock to redemption value			(983,176)	(983,176)
Net income (loss)			(816,133)	(816,133)
Balance at Sep. 30, 2022	$ 228		(3,888,983)	(3,888,755)
Balance (in Shares) at Sep. 30, 2022	2,283,976
Balance at Dec. 31, 2022	$ 228		(5,939,864)	$ (5,939,636)
Balance (in Shares) at Dec. 31, 2022	2,283,976			2,283,976
Accretion of redeemable common stock to redemption value			(750,670)	$ (750,670)
Net income (loss)			(230,201)	(230,201)
Balance at Mar. 31, 2023	$ 228		(6,920,735)	(6,920,507)
Balance (in Shares) at Mar. 31, 2023	2,283,976
Balance at Dec. 31, 2022	$ 228		(5,939,864)	$ (5,939,636)
Balance (in Shares) at Dec. 31, 2022	2,283,976			2,283,976
Net income (loss)				$ (39,380)
Balance at Sep. 30, 2023	$ 228		(8,987,606)	$ (8,987,378)
Balance (in Shares) at Sep. 30, 2023	2,283,976			2,283,976
Balance at Mar. 31, 2023	$ 228		(6,920,735)	$ (6,920,507)
Balance (in Shares) at Mar. 31, 2023	2,283,976
Accretion of redeemable common stock to redemption value			(722,985)	(722,985)
Net income (loss)			26,528	26,528
Balance at Jun. 30, 2023	$ 228		(7,617,192)	(7,616,964)
Balance (in Shares) at Jun. 30, 2023	2,283,976
Accretion of redeemable common stock to redemption value			(951,187)	(951,187)
Excise tax on redemption of Class A common stock			(583,520)	(583,520)
Net income (loss)			164,293	164,293
Balance at Sep. 30, 2023	$ 228		$ (8,987,606)	$ (8,987,378)
Balance (in Shares) at Sep. 30, 2023	2,283,976			2,283,976

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (39,380)	$ (1,594,068)
Adjustments to reconcile net loss to net cash used in operating activities:
Income on investments held in Trust Account	(1,855,102)	(461,133)
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(17,121)	320,216
Due to affiliates	58,000	119,490
Accounts payable	973,107	727,668
Franchise tax payable	172,771	70,642
Income taxes payable	7,489	52,582
Net cash provided by (used in) operating activities	(700,236)	(764,603)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash deposited to Trust Account	(750,000)	(3,049,628)
Notes receivable - related party	(124,166)
Repayment of notes receivable - related party	124,166
Cash withdrawn from Trust Account in connection with redemption	42,636,600
Net cash provided by (used in) investing activities	41,886,600	(3,049,628)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of over-allotment option		2,276,860
Proceeds from sale of private units to sponsor		45,540
Payment of offering costs		(45,538)
Redemption of common stock - due to stockholders	(42,636,600)
Proceeds from convertible promissory notes and working capital loans - related party	1,234,934	772,769
Net cash (used in) provided by financing activities	(41,401,666)	3,049,631
NET CHANGE IN CASH AND RESTRICTED CASH	(215,302)	(764,600)
CASH AND RESTRICTED CASH, BEGINNING OF PERIOD	523,063	1,200,956
CASH AND RESTRICTED CASH, END OF PERIOD	307,761	436,356
Cash	94,579	436,356
Restricted cash	213,182
CASH AND RESTRICTED CASH, END OF PERIOD	307,761	436,356
Supplemental disclosure on noncash activities:
Deferred underwriting commission payable		79,690
Accretion for redeemable common stock to redemption value	2,424,842
Excise tax on redemption of Class A common stock	583,520
Due to shareholders for redemption of Common Stock	$ 15,715,387

Description of Organization and Business Operations and Liquidity

9 Months Ended

Sep. 30, 2023

Description of Organization and Business Operations and Liquidity [Abstract]

Description of Organization and Business Operations and Liquidity

Note 1 — Description of Organization and Business Operations and Liquidity

Risks and Uncertainties

Going Concern, Liquidity and Capital Resources

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

Principles of Consolidation

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Restricted Cash

Investments Held in Trust Account

Offering Costs associated with the IPO and over-allotment

Concentration of Credit Risk

Fair Value of Financial Instruments

Income Taxes

Common Stock Subject to Possible Redemption

The shares of common stock reflected on the condensed consolidated balance sheets are reconciled on the following table:

	September 30, 2023			December 31, 2022
Gross proceeds	$	79,514,266		$	77,276,860
Less:
Fair value of Public Rights at issuance		—			(2,627,413	)
Public shares issuance costs		—			(4,626,437	)
Redemptions		(58,351,987	)		—
Plus:
Accretion of carrying value to redemption value		2,424,842			9,491,256
Redeemable ordinary shares subject to possible redemption	$	23,587,121		$	79,514,266

Net Income (Loss) per Common Share

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2023				2022						2023						2022
	Redeemable		Non- redeemable		Redeemable			Non- redeemable			Redeemable			Non- redeemable			Redeemable			Non- redeemable
Basic and diluted net income (loss) per common share
Numerator:
Allocation of net income (loss)	$	100,498	$	63,795	$	(633,549	)	$	(182,584	)	$	(26,772	)	$	(12,608	)	$	(1,264,241	)	$	(329,827	)
Denominator:
Basic and diluted weighted average shares outstanding		3,598,051		2,283,976		7,727,686			2,227,054			4,849,939			2,283,976			7,716,804			2,013,230

Basic and diluted net income (loss) per common share	$	0.03	$	0.03	$	(0.08	)	$	(0.08	)	$	(0.01	)	$	(0.01	)	$	(0.16	)	$	(0.16	)

Recent Accounting Pronouncements

Initial Public Offering and Over-Allotment

9 Months Ended

Sep. 30, 2023

Initial Public Offering and Over-Allotment [Abstract]

Initial Public Offering and Over-Allotment

Note 3 — Initial Public Offering and Over-Allotment

The Company granted the underwriters a 45-day option to purchase up to 1,125,000 Units to cover Over-allotment, if any. On January 14, 2022, the underwriters partially exercised the option and purchased 227,686 additional Units (the “Over-allotment Units”).

Private Placement

9 Months Ended

Sep. 30, 2023

Private Placement [Abstract]

Private Placement

Note 4 — Private Placement

On January 14, 2022, the Company consummated the sale of an additional 4,554 Private Placement Units, at $10.00 per Private Placement Unit for an aggregate purchase price of $45,540.

Related Party Transactions

9 Months Ended

Sep. 30, 2023

Related Party Transactions

Note 5 — Related Party Transactions

Founder Shares

Promissory Note – Related Party

Due to Affiliates

Related Party Loans

On July 30, 2023, the Company issued a promissory note (the “Working Capital Note 1”) in the principal amount of $84,000 to the Sponsor in exchange for cash.

On August 30, 2023, the Company issued a promissory note (the “Working Capital Note 2”) in the principal amount of $378,000 to the Sponsor in exchange for cash.

As of September 30, 2023 and December 31, 2022, there were $484,100 and $0, respectively, outstanding under the Working Capital Notes.

Convertible Promissory Note – Related Party

As of September 30, 2023 and December 31, 2022, there were $2,296,371 and $1,545,537, respectively, outstanding under the Promissory Notes.

Notes Receivable – Related Party

Support Services

Commitments and Contingencies

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies [Abstract]

Commitments and Contingencies

Note 6 — Commitments and Contingencies

Registration Rights

Underwriting Agreement

Service Provider Agreements

Backstop Agreement

Non-redemption Agreement

Advisory Agreement

Stockholders’ Deficit

9 Months Ended

Sep. 30, 2023

Stockholders’ Deficit [Abstract]

Stockholders’ Deficit

Note 7 — Stockholders’ Deficit

Fair Value Measurements

9 Months Ended

Sep. 30, 2023

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 8 — Fair Value Measurements

Level 1:

Level 2:

Level 3:

Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

On October 12, 2023, $15,715,387 in connection with redemption of common stock, which includes $554,273 of the interest earned on the Trust Account distributed to the stockholders (Note 9).

September 30, 2023

Quoted
Prices in
Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

(Level 1)

(Level 2)

(Level 3)

Assets:

Cash and U.S. Treasury Securities

39,613,658

—

December 31, 2022

Quoted
Prices in
Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

(Level 1)

(Level 2)

(Level 3)

Assets:

Cash and U.S. Treasury Securities

79,645,156

—

Subsequent Events

9 Months Ended

Sep. 30, 2023

Subsequent Events [Abstract]

Subsequent Events

Note 9 — Subsequent Events

Accounting Policies, by Policy (Policies)

9 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Principles of Consolidation

Principles of Consolidation

Emerging Growth Company

Emerging Growth Company

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

Restricted Cash

Restricted Cash

Investments Held in Trust Account

Investments Held in Trust Account

Offering Costs associated with the IPO and over-allotment

Offering Costs associated with the IPO and over-allotment

Concentration of Credit Risk

Concentration of Credit Risk

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Income Taxes

Income Taxes

Common Stock Subject to Possible Redemption

Common Stock Subject to Possible Redemption

The shares of common stock reflected on the condensed consolidated balance sheets are reconciled on the following table:

	September 30, 2023			December 31, 2022
Gross proceeds	$	79,514,266		$	77,276,860
Less:
Fair value of Public Rights at issuance		—			(2,627,413	)
Public shares issuance costs		—			(4,626,437	)
Redemptions		(58,351,987	)		—
Plus:
Accretion of carrying value to redemption value		2,424,842			9,491,256
Redeemable ordinary shares subject to possible redemption	$	23,587,121		$	79,514,266

Net Income (Loss) per Common Share

Net Income (Loss) per Common Share

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2023				2022						2023						2022
	Redeemable		Non- redeemable		Redeemable			Non- redeemable			Redeemable			Non- redeemable			Redeemable			Non- redeemable
Basic and diluted net income (loss) per common share
Numerator:
Allocation of net income (loss)	$	100,498	$	63,795	$	(633,549	)	$	(182,584	)	$	(26,772	)	$	(12,608	)	$	(1,264,241	)	$	(329,827	)
Denominator:
Basic and diluted weighted average shares outstanding		3,598,051		2,283,976		7,727,686			2,227,054			4,849,939			2,283,976			7,716,804			2,013,230

Basic and diluted net income (loss) per common share	$	0.03	$	0.03	$	(0.08	)	$	(0.08	)	$	(0.01	)	$	(0.01	)	$	(0.16	)	$	(0.16	)

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Schedule of Common Stock Reflected on the Consolidated Balance Sheets

The shares of common stock reflected on the condensed consolidated balance sheets are reconciled on the following table:

	September 30, 2023			December 31, 2022
Gross proceeds	$	79,514,266		$	77,276,860
Less:
Fair value of Public Rights at issuance		—			(2,627,413	)
Public shares issuance costs		—			(4,626,437	)
Redemptions		(58,351,987	)		—
Plus:
Accretion of carrying value to redemption value		2,424,842			9,491,256
Redeemable ordinary shares subject to possible redemption	$	23,587,121		$	79,514,266

Schedule of Basic and Diluted Net Loss Per Common Share

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

	For the Three Months Ended September 30,										For the Nine Months Ended September 30,
	2023				2022						2023						2022
	Redeemable		Non- redeemable		Redeemable			Non- redeemable			Redeemable			Non- redeemable			Redeemable			Non- redeemable
Basic and diluted net income (loss) per common share
Numerator:
Allocation of net income (loss)	$	100,498	$	63,795	$	(633,549	)	$	(182,584	)	$	(26,772	)	$	(12,608	)	$	(1,264,241	)	$	(329,827	)
Denominator:
Basic and diluted weighted average shares outstanding		3,598,051		2,283,976		7,727,686			2,227,054			4,849,939			2,283,976			7,716,804			2,013,230

Basic and diluted net income (loss) per common share	$	0.03	$	0.03	$	(0.08	)	$	(0.08	)	$	(0.01	)	$	(0.01	)	$	(0.16	)	$	(0.16	)

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Measurements [Abstract]

Schedule of Liabilities Measured at Fair Value on a Recurring Basis

indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

Quoted
Prices in
Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

(Level 1)

(Level 2)

(Level 3)

Assets:

Cash and U.S. Treasury Securities

39,613,658

—

Quoted
Prices in
Active
Markets

Significant
Other
Observable
Inputs

Significant
Other
Unobservable
Inputs

(Level 1)

(Level 2)

(Level 3)

Assets:

Cash and U.S. Treasury Securities

79,645,156

—

Description of Organization and Business Operations and Liquidity (Details) - USD ($)			1 Months Ended			9 Months Ended
	Jan. 14, 2022	Dec. 30, 2021	Sep. 29, 2023	Mar. 24, 2023	Aug. 16, 2022	Sep. 30, 2023	Oct. 12, 2023	Sep. 08, 2023	Aug. 29, 2023	Aug. 01, 2023	Jun. 29, 2023	May 26, 2023	Apr. 27, 2023	Apr. 10, 2023	Mar. 28, 2023	Dec. 31, 2022	Dec. 23, 2022	Sep. 30, 2022	Sep. 27, 2022
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Shares issued (in Shares)			1,456,871			347,500		500,000
Share price (in Dollars per share)				$ 10		$ 10
Generating gross proceeds		$ 75,000,000
Shares issued units (in Shares)						1,125,000
Percentage of outstanding						50.00%
Net tangible assets						$ 5,000,001
Common stock percentage						20.00%
Company’s obligation to redeem percentage						100.00%
Dissolution expenses						$ 100,000
Deposit									$ 125,000	$ 125,000	$ 125,000	$ 125,000	$ 125,000		$ 125,000		$ 772,769		$ 772,769
Deposit trust account				$ 125,000
Exercised shares (in Shares)			1,456,871	4,097,964
Cash redemption price (in Dollars per share)			$ 10.79	$ 10.4		$ 10.86										$ 10.29
Aggregate redemption amount			$ 15,700,000	$ 42,600,000			$ 15,715,387
Trust account			$ 23,400,000			$ 39,613,658		$ 25,000,000								$ 79,645,156
Shares exercising price														$ 42,636,600
U.S. federal excise tax				1.00%	1.00%
Excise tax					1.00%	1.00%
Stockholders redeemed Common shares (in Shares)			1,456,871	4,097,964
Redeemed common shares, value			$ 15,715,837	$ 42,636,600										$ 42,636,600
Sales and Excise Tax Payable, Current						$ 583,520
Cash						94,579												$ 436,356
Restricted cash						213,182										$ 213,182
Working capital deficit						$ 6,807,020
Financial term						1 year
IPO [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Shares issued (in Shares)		7,500,000
Share price (in Dollars per share)						$ 10
Net proceeds	$ 77,276,860
Offering cost						$ 4,788,446
Underwriting fees						1,545,537
Deferred underwriting fee payable						2,704,690
Other costs						538,219
Sale of net proceeds						$ 75,000,000
Private Placement Units [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Share price (in Dollars per share)	$ 10					$ 10
Generating gross proceeds	$ 45,540
Shares issued units (in Shares)	4,554
Over-Allotment Option [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Generating gross proceeds	$ 2,276,860
Shares issued units (in Shares)	227,686
Common Stock [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Shares issued units (in Shares)	224,328
Trust Account [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Trust account				80,400,000
Trust Account [Member] \| Common Stock [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Trust account				$ 37,800,000
Sponsor [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Generating gross proceeds						$ 3,475,000
Business Combination [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Deferred underwriting fee payable						$ 2,704,690
Percentage of aggregate fair market value						80.00%
Trust account per shares (in Dollars per share)						$ 10
Business Combination [Member] \| IPO [Member]
Description of Organization and Business Operations and Liquidity (Details) [Line Items]
Share price (in Dollars per share)		$ 10

Summary of Significant Accounting Policies (Details) - USD ($)				3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 29, 2023	Mar. 24, 2023	Dec. 31, 2022	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Sep. 27, 2023	Sep. 08, 2023	Jun. 30, 2023	Apr. 10, 2023	Mar. 22, 2023	Dec. 30, 2021
Summary of Significant Accounting Policies [Abstract]
Withdrawn from trust account							$ 42,636,600
Franchise taxes					$ 85,232
Restricted cash withdrawal amount			$ 213,182	$ 213,182	$ 213,182		213,182		$ 213,182
Restricted cash deficiency												$ 142,851
Balance amount							$ 213,182		$ 213,182
Effective tax rate				(268.30%)		6.89%	0.00%	3.41%
Statutory tax rate				21.00%		21.00%	21.00%	21.00%
Shares of common stock (in Shares)		4,097,964
Redemption price (in Dollars per share)	$ 10.79	$ 10.4	$ 10.29	$ 10.86	$ 10.29		$ 10.86		$ 10.29
Aggregate redemption amount	$ 15,700,000	$ 42,600,000
Assets held in trust	23,400,000									$ 39,600,000				$ 80,400,000
Redeem amount	$ 15,715,837	42,636,600											$ 42,636,600
Shares of common stock (in Shares)	1,456,871			347,500			347,500				500,000
Common stock subject to possible redemption			$ 79,514,266	$ 23,587,121	$ 79,514,266		$ 23,587,121		$ 79,514,266
Sponsor [Member]
Summary of Significant Accounting Policies [Abstract]
Restricted cash deficiency				213,182			213,182
IPO [Member]
Summary of Significant Accounting Policies [Abstract]
Offering costs							4,663,218
Shares of common stock (in Shares)															7,500,000
Over-Allotment Option [Member]
Summary of Significant Accounting Policies [Abstract]
Offering costs							125,228
Common Stock [Member]
Summary of Significant Accounting Policies [Abstract]
Aggregate redemption amount		42,600,000
Assets held in trust		$ 37,800,000
Common stock subject to possible redemption			7,727,686	$ 2,172,851	$ 7,727,686		$ 2,172,851		$ 7,727,686
Restricted Cash [Member]
Summary of Significant Accounting Policies [Abstract]
Withdrawn from trust account			$ 298,414

Summary of Significant Accounting Policies (Details) - Schedule of Common Stock Reflected on the Consolidated Balance Sheets - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Schedule of Common Stock Reflected on the Consolidated Balance Sheets [Abstract]
Gross proceeds	$ 79,514,266	$ 77,276,860
Less:
Fair value of Public Rights at issuance		(2,627,413)
Public shares issuance costs		(4,626,437)
Redemptions	(58,351,987)
Plus:
Accretion of carrying value to redemption value	2,424,842	9,491,256
Redeemable ordinary shares subject to possible redemption	$ 23,587,121	$ 79,514,266

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Common Share - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Redeemable [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Common Share [Line Items]
Allocation of net income (loss)	$ 100,498	$ (633,549)	$ (26,772)	$ (1,264,241)
Basic and diluted weighted average shares outstanding	3,598,051	7,727,686	4,849,939	7,716,804
Basic and diluted net income (loss) per common share	$ 0.03	$ (0.08)	$ (0.01)	$ (0.16)
Non- redeemable [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Common Share [Line Items]
Allocation of net income (loss)	$ 63,795	$ (182,584)	$ (12,608)	$ (329,827)
Basic and diluted weighted average shares outstanding	2,283,976	2,227,054	2,283,976	2,013,230
Basic and diluted net income (loss) per common share	$ 0.03	$ (0.08)	$ (0.01)	$ (0.16)

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Common Share (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Redeemable [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Common Share (Parentheticals) [Line Items]
Diluted weighted average shares outstanding	3,598,051	7,727,686	4,849,939	7,716,804
Diluted net income (loss) per common share	$ 0.03	$ (0.08)	$ (0.01)	$ (0.16)
Non- redeemable [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Common Share (Parentheticals) [Line Items]
Diluted weighted average shares outstanding	2,283,976	2,227,054	2,283,976	2,013,230
Diluted net income (loss) per common share	$ 0.03	$ (0.08)	$ (0.01)	$ (0.16)

Initial Public Offering and Over-Allotment (Details) - USD ($)				9 Months Ended
	Sep. 29, 2023	Mar. 24, 2023	Jan. 14, 2022	Sep. 30, 2023	Sep. 08, 2023	Dec. 31, 2022
Initial Public Offering and Over-Allotment (Details) [Line Items]
Common stock shares (in Shares)	1,456,871	4,097,964		2,283,976	100,000	2,283,976
Temporary Equity, Redemption Price Per Share (in Dollars per share)	$ 10.79	$ 10.4		$ 10.86		$ 10.29
Aggregate redemption amount	$ 15,700,000	$ 42,600,000
Trust account	23,400,000	37,800,000
Held in trust account	$ 39,600,000	$ 80,400,000		$ 298,414
IPO [Member]
Initial Public Offering and Over-Allotment (Details) [Line Items]
Sale of stock units (in Shares)				7,500,000
Price per unit (in Dollars per share)				$ 10
Over-Allotment Option [Member]
Initial Public Offering and Over-Allotment (Details) [Line Items]
Purchase of share units (in Shares)				1,125,000
Additional Units (in Shares)			227,686

Private Placement (Details) - USD ($)			9 Months Ended
Private Placement (Details) - USD ($)	Jan. 14, 2022	Dec. 27, 2021	Sep. 30, 2023	Sep. 30, 2022
Private Placement [Line Items]
Gross proceeds				$ 45,540
Aggregate purchase price	$ 45,540
Private Placement [Member]
Private Placement [Line Items]
Issuance and sale of private placement units		347,500
Private placement transaction price per share		$ 10
Gross proceeds		$ 3,475,000
Private placement, description		Each Private Placement Unit consists of one share of common stock and one right to receive one-tenth (1/10) of a share of common stock upon consummation of a Business Combination.
Sale of additional shares	4,554
Private placement units per share	$ 10

Related Party Transactions (Details) - USD ($)				1 Months Ended												3 Months Ended		9 Months Ended			12 Months Ended
Related Party Transactions (Details) - USD ($)	Jul. 03, 2023	Jan. 14, 2022	Oct. 13, 2021	Sep. 28, 2023	Aug. 30, 2023	Jul. 30, 2023	Jun. 27, 2023	May 26, 2023	May 25, 2023	Mar. 30, 2023	Dec. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 27, 2021	Jun. 25, 2021	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 28, 2023	Sep. 30, 2022	Dec. 31, 2022
Related Party Transactions (Details) [Line Items]
Common stock, par value (in Dollars per share)																$ 0.0001		$ 0.0001			$ 0.0001
Forfeited shares (in Shares)		224,328
Limited exceptions percentage																		50.00%
Aggregate purchase price		$ 259,136
Amount paid																$ 263,663		$ 263,663
Amount repaid																					$ 205,663
Working capital loans																		1,500,000	$ 1,500,000
Price per share (in Dollars per share)				$ 10															$ 10
Principal amount				$ 22,000	$ 378,000	$ 84,000				$ 125,000	$ 772,769	$ 772,769
Balance Outstanding Working Capital Notes																		$ 484,100			0
Business combination into additional private units										$ 10	$ 10	$ 10
Post business combination price per unit (in Dollars per share)																		$ 10
Balance outstanding promissory note																		$ 2,296,371			$ 1,545,537
Principal amount									$ 125,000
Repaid amount	$ 99,166						$ 25,000	$ 124,166
Sponsor fees														$ 10,000
Other Expenses																$ 30,000	$ 30,000			$ 90,000
IPO [Member]
Related Party Transactions (Details) [Line Items]
Aggregate units															$ 300,000
Private Placement Units [Member]
Related Party Transactions (Details) [Line Items]
Sponsor funded		179,463											$ 79,673
Aggregate purchase price		$ 45,540											$ 3,475,000
Price per share (in Dollars per share)																$ 10		$ 10
Class B Common Stock [Member]
Related Party Transactions (Details) [Line Items]
Shares of our common stock (in Shares)			1.5
Chief Financial Officer [Member]
Related Party Transactions (Details) [Line Items]
Other Expenses																		$ 90,000
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Issuance of share (in Shares)			2,156,250
Aggregate price amount															$ 25,000
Founder Shares [Member] \| Over-Allotment Option [Member]
Related Party Transactions (Details) [Line Items]
Forfeited shares (in Shares)			281,250
Founder Shares [Member] \| Class B Common Stock [Member]
Related Party Transactions (Details) [Line Items]
Issuance of share (in Shares)															1,437,500
Common stock, par value (in Dollars per share)															$ 0.0001
Founder Shares [Member] \| Business Combination [Member]
Related Party Transactions (Details) [Line Items]
Common stock share (in Dollars per share)																$ 12.5		$ 12.5
Initial business combination percentage																50.00%		50.00%

Commitments and Contingencies (Details) - USD ($)			9 Months Ended
Commitments and Contingencies (Details) - USD ($)	Sep. 29, 2023	Jan. 14, 2022	Sep. 30, 2023	Sep. 08, 2023	Mar. 24, 2023	Dec. 31, 2022
Commitments and Contingencies [Line Items]
Underwriting fee per unit (in Dollars per share)			$ 0.2
Aggregate underwriting fee (in Dollars)			$ 1,545,537
Additional underwriting payable per share (in Dollars per share)			$ 0.35
Aggregate deferred underwriting payable (in Dollars)			$ 2,704,690
Redeemable common stock	2,432,185
Trust account (in Dollars)	$ 23,400,000		$ 39,613,658	$ 25,000,000		$ 79,645,156
Shares	1,456,871		347,500	500,000
Common stock shares	1,456,871		2,283,976	100,000	4,097,964	2,283,976
Over-Allotment Option [Member]
Commitments and Contingencies [Line Items]
Purchase of additional units		227,686	1,125,000
Offering price (in Dollars per share)		$ 10
Additional gross proceeds (in Dollars)		$ 2,276,860

Stockholders’ Deficit (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Oct. 13, 2021	Jun. 25, 2021
Stockholders’ Deficit [Abstract]
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock outstanding	2,283,976	2,283,976
Common stock subject to shares at redemption	2,172,851	7,727,686
Class B Common Stock [Member]
Stockholders’ Deficit [Abstract]
Sponsor shares			1.5	1,437,500
Aggregate purchase price (in Dollars)				$ 25,000
Aggregate of founder shares			2,156,250

Fair Value Measurements (Details) - USD ($)	9 Months Ended
Fair Value Measurements (Details) - USD ($)	Sep. 30, 2023	Oct. 12, 2023	Sep. 29, 2023	Mar. 24, 2023
Fair Value Measurements [Line Items]
Company withdrew amount	$ 42,636,600
Redemption of common stock	837,367
Trust account	298,414		$ 39,600,000	$ 80,400,000
Income tax amount	$ 213,182
Redemption of common stock value		$ 15,715,387	$ 15,700,000	$ 42,600,000
Interest earned		$ 554,273

Fair Value Measurements (Details) - Schedule of Liabilities Measured at Fair Value on a Recurring Basis - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Quoted Prices in Active Markets (Level 1) [Member]
Assets:
Cash and U.S. Treasury Securities	$ 39,613,658	$ 79,645,156
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Cash and U.S. Treasury Securities
Significant Other Observable Inputs (Level 3) [Member]
Assets:
Cash and U.S. Treasury Securities

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Nov. 10, 2023	Oct. 12, 2023
Subsequent Events (Details) [Line Items]
Holders of shares		$ 15,715,387
Principal amount	$ 50,000
Working capital loan	$ 534,000

Welsbach Technology Meta... (NASDAQ:WTMA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Welsbach Technology Meta... Charts.

Welsbach Technology Meta... (NASDAQ:WTMA)
Historical Stock Chart
From May 2023 to May 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

WTMA Welsbach Technology Metals Acquisition Corporation

Welsbach Technology Metals Acquisition Corporation News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

WTMA Welsbach Technology Metals Acquisition Corporation

Welsbach Technology Metals Acquisition Corporation News

Your Recent History

Company

Business

Popular

Get The App